Amgen
Search results
Biogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. Biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity through science while ...
- Pipeline
With a strong focus on difficult-to-treat diseases, our...
- News Releases
Biogen to Report Second Quarter 2024 Financial Results...
- Contact Us
Alzheimer’s Support Alzheimer’s Support Services...
- Multiple Sclerosis (MS)
Multiple sclerosis (MS) is a complex, heterogeneous, chronic...
- Leadership Team
Meet our executive leadership team. Inspired by the science:...
- Investor Relations
Biogen. Corporate Profile. Founded in 1978, Biogen is a...
- Responsibility
For Biogen, that includes bolstering our commitment to...
- Alzheimer's Disease
Biogen has signed agreements with the National Association...
- Pipeline
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide. Biogen operates in Argentina, Brazil, Canada, China, France, Germany, Hungary, India, Italy, Japan ...
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.
With a strong focus on difficult-to-treat diseases, our pipeline is focused on research in therapeutic areas where we believe we have the best opportunity to deliver transformational medicines to patients and protect public health.
The potential to transform the lives of patients is what drives us at Biogen. As a leading global biotechnology company, we work toward those once-in-a-lifetime moments that could become a historic point in our pursuit of innovative treatments.
May 22, 2024 · Biogen plans to leverage its existing global development and commercialization capabilities in rare disease and its strong scientific expertise in immunology to support the advancement of felzartamab and the HI-Bio pipeline.
Biogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. Biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialised immunology and rare disease and remains acutely focused on its purpose of serving humanity through science while ...
People also ask
What does Biogen do?
Is Biogen a drug candidate?
Is Biogen a stock?
What are Biogen's new products?
